计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
G421970-1ml |
1ml |
现货 ![]() |
|
英文别名 | BCP31015 | 5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide | EX-A3069 | (S)-5-Benzyl-N-(7,9-difluoro-2-oxo-2,3,4,5-tetrahydro-1hbenzo(b)azepin-3-yl)-1H-1,2,4-triazole-3-carboxamide (7,7-dimethyl-2- |
---|---|
规格或纯度 | Moligand™, 10mM in DMSO |
英文名称 | GSK3145095 |
生化机理 | GSK3145095 是一种强效的口服活性 RIP1 激酶抑制剂,其 IC50 值为 6.3 nM,具有潜在的抗肿瘤和免疫调节活性。 |
储存温度 | -80℃储存 |
运输条件 | 超低温冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | 受体相互作用丝氨酸/苏氨酸激酶 1 抑制剂 |
产品介绍 |
Information GSK3145095 GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities. Targets RIP1 kinase (Cell-free assay) 6.3 nM In vitro GSK3145095 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking RIP1 kinasedependent cellular responses. Highlighting its potential as a novel cancer therapy, the inhibitor is also able to promote a tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures. Cell Research(from reference) Cell lines:U937 cells, L-cells NCTC 929 (L929) cells Concentrations:0-3 μM Incubation Time:5 h |
ALogP | 2.573 |
---|---|
hba_count | 4 |
HBD Count | 3 |
Rotatable Bond | 4 |
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
分子类型 | 未知 |
---|---|
IUPAC Name | 5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide |
INCHI | InChI=1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1 |
InChi Key | ATQAGKAMBISZQM-HNNXBMFYSA-N |
Canonical SMILES | C1CC2=C(C(=CC(=C2)F)F)NC(=O)C1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4 |
Isomeric SMILES | C1CC2=C(C(=CC(=C2)F)F)NC(=O)[C@H]1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4 |
分子量 | 397.38 |
Reaxy-Rn | 60346311 |
Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=60346311&ln= |
DMSO(mg / mL) Max Solubility | 79 |
---|---|
DMSO(mM) Max Solubility | 198.802154109417 |
Water(mg / mL) Max Solubility | <1 |
分子量 | 397.400 g/mol |
XLogP3 | 3.100 |
氢键供体数Hydrogen Bond Donor Count | 3 |
氢键受体数Hydrogen Bond Acceptor Count | 6 |
可旋转键计数Rotatable Bond Count | 4 |
精确质量Exact Mass | 397.135 Da |
单同位素质量Monoisotopic Mass | 397.135 Da |
拓扑极表面积Topological Polar Surface Area | 99.800 Ų |
重原子数Heavy Atom Count | 29 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 603.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Reaxy-Rn | 60346311 |
---|---|
Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=60346311&ln= |
Concentration(Compounding value) | 9.0-11.0(mmol/L) |
---|---|
Appearance(Colorless Transparent Liquid) | Pass |
Record the entire process by video | Conform |